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ARTICLE
Genotoxic stress triggers the activation of
IRE1α-dependent RNA decay to modulate
the DNA damage response
Estefanie Dufey1,2,3, José Manuel Bravo-San Pedro4,5, Cristian Eggers6,7, Matías González-Quiroz 1,2,3,8,9,
Hery Urra1,2,3, Alfredo I. Sagredo1,2,3, Denisse Sepulveda1,2,3, Philippe Pihán1,2,3, Amado Carreras-Sureda1,2,3,
Younis Hazari1,2,3, Eduardo A. Sagredo10, Daniela Gutierrez11, Cristian Valls11, Alexandra Papaioannou 8,9,
Diego Acosta-Alvear12,13,14, Gisela Campos15, Pedro M. Domingos 16, Rémy Pedeux8,9, Eric Chevet 8,9,
Alejandra Alvarez11, Patricio Godoy15, Peter Walter 12,13, Alvaro Glavic6,7, Guido Kroemer 4,5,17,18,19 &
Claudio Hetz 1,2,3,20✉
The molecular connections between homeostatic systems that maintain both genome
integrity and proteostasis are poorly understood. Here we identify the selective activation of
the unfolded protein response transducer IRE1α under genotoxic stress to modulate repair
programs and sustain cell survival. DNA damage engages IRE1α signaling in the absence of an
endoplasmic reticulum (ER) stress signature, leading to the exclusive activation of regulated
IRE1α-dependent decay (RIDD) without activating its canonical output mediated by the
transcription factor XBP1. IRE1α endoribonuclease activity controls the stability of mRNAs
involved in the DNA damage response, impacting DNA repair, cell cycle arrest and apoptosis.
The activation of the c-Abl kinase by DNA damage triggers the oligomerization of IRE1α to
catalyze RIDD. The protective role of IRE1α under genotoxic stress is conserved in fly and
mouse. Altogether, our results uncover an important intersection between the molecular
pathways that sustain genome stability and proteostasis.
https://doi.org/10.1038/s41467-020-15694-y OPEN
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The integrity of the genome is constantly threatened byendogenously produced toxic metabolites, physical, andchemical insults, resulting in a variety of DNA lesions.
Inefficient DNA repair translates into cellular dysfunction and
death, but also into the propagation of somatic mutations and
malignant transformation. To limit genome instability, cells
engage the DNA damage response (DDR) and activate repair
mechanisms to reverse or minimize alterations in DNA integrity1.
The DDR pathway involves the interconnection of complex sig-
naling networks that enforce cell cycle arrest and DNA repair.
The failure of this adaptive mechanism is detrimental for the cell,
resulting in an irreversible cell cycle arrest (senescence) or the
activation of different types of regulated death programs1.
Accordingly, perturbations in the DDR largely contribute to
oncogenesis, tumor progression, and the resistance to irradiation
and chemotherapy with genotoxic drugs. The accumulation of
synonymous mutations, aneuploidy, as well as the activation of
oncogenes, deregulate proteostasis2. The endoplasmic reticulum
(ER) is the main subcellular compartment involved in protein
folding and quality control3, representing a central node of the
proteostasis network. The unfolded protein response (UPR) is a
specialized mechanism to cope with ER stress4,5, that also influ-
ences most hallmarks of cancer6. Nevertheless, the possible
involvement of the UPR in the surveillance and maintenance of
genome integrity remains elusive.
Inositol requiring enzyme 1 alpha (known as ERN1, referred to
as IRE1α hereafter) controls the most evolutionary conserved
UPR signaling branch, regulating ER proteostasis and cell survival
through distinct functional outputs4. IRE1α is a serine/threonine
protein kinase and endoribonuclease that catalyzes the uncon-
ventional splicing of the mRNA encoding X-Box binding protein
1 (Xbp1), generating an active transcription factor that enforces
adaptive programs7. IRE1α also degrades a subset of mRNAs and
microRNAs through a process known as regulated IRE1α-
dependent decay of RNA (RIDD), impacting various biological
processes, including cell death and inflammation8–11. A screen
aiming to define the universe of XBP1-target genes under ER
stress identified a cluster of DDR-related components12, and
suboptimal DNA repair may trigger ER stress2. Together, these
observations suggest a link between DNA damage and ER pro-
teostasis. Here we investigate the possible contribution of IRE1α
to the DDR. Surprisingly, we observed that genotoxic stress
engages IRE1α signaling in the absence of ER stress markers. In
fibroblasts undergoing DNA damage, IRE1α activation results in
the selective activation of RIDD in the absence of XBP1 mRNA
splicing, impacting genome stability, cell survival and cell cycle
control. At the molecular level, we identify specific RIDD mRNA
substrates as possible effectors of the phenotypes triggered by
IRE1α deficiency. We also validated the significance of IRE1α
signaling to the DDR in vivo using genetic manipulation in
mouse and fly models. Our results suggest that IRE1α has an
alternative function in cells undergoing genotoxic stress, where it
serves to amplify and sustain an efficient DDR to maintain
genome stability and cell survival.
Results
DNA damage selectively induces IRE1α signaling toward
RIDD. Upon ER stress, IRE1α dimerization leads to its auto-
transphosphorylation and the formation of large clusters that are
needed for optimal signaling13. Exposure of mouse embryonic
fibroblasts (MEF) to the DNA damaging agent etoposide, a topoi-
somerase II inhibitor, triggers mild IRE1α phosphorylation (Fig. 1a)
and formation of IRE1α clusters, as revealed using an IRE1α-GFP
reporter (Fig. 1b). Similar results were obtained in cells exposed to
γ-irradiation (Supplementary Fig. 1a). Unexpectedly, MEF cells
stimulated with etoposide or γ-irradiation failed to engage Xbp1
mRNA splicing, as determined by two independent PCR-based
assays (Fig. 1c, d) or western blot analysis (Supplementary Fig. 1b).
Moreover, no signs of ER stress were observed in cells undergoing
DNA damage when we assessed canonical markers of UPR acti-
vation, including the expression of CHOP, ATF4, BiP, as well as
ATF6 processing and the phosphorylation of both PERK and eIF2α
(Supplementary Fig. 1c, d). As positive controls of DNA damage,
we monitored the levels of phosphorylation of the histone H2AX
(γ-H2AX) or the upregulation of the cyclin-dependent kinase
inhibitor CDKN1A (also known as p21) (Supplementary Fig. 1b, d).
Unexpectedly, classical RIDD mRNAs substrates such as Bloc1s1
and Sparc8,9 decayed upon exposure to DNA damaging agents
(Fig. 1e). Importantly, this decrease in Bloc1s1 and Sparc mRNAs
did not occur in IRE1α-deficient cells (Fig. 1e), nor upon phar-
macological inhibition of the RNase activity of IRE1α with MKC-
8866 (Supplementary Fig. 1e, f), confirming the occurrence of
RIDD. These results suggest that DNA damage selectively stimu-
lates IRE1α activity toward RIDD and not Xbp1 mRNA splicing in
the absence of global ER stress markers.
IRE1α regulates DDR signaling under genotoxic stress. To
evaluate the significance of IRE1α expression to the adaptive
capacity of cells undergoing DNA damage, we compared the
viability of IRE1α-deficient and control (wild type, WT) cells after
exposure to various agents that induce distinct types of DNA
lesions, including etoposide, 5-hydroxyurea, 5-fluorouracil, and
γ-irradiation. Remarkably, IRE1α deficiency sensitized cells to all
types of genotoxic stress, thus increasing the incidence of cell
death (Fig. 1f and Supplementary Fig. 2a). We confirmed these
results by measuring caspase-3 activation, a marker of apoptosis
(Fig. 1g). We then stably reconstituted IRE1α null cells with an
HA-tagged version of IRE1α (IRE1α-HA) that expresses levels
similar to endogenous (described in refs. 14,15). Importantly, the
hypersensitivity of IRE1α deficient cells to DNA damage was
partially reverted by expressing IRE1α-HA, suggesting that the
phenotypes observed in IRE1α-deficient cells under genotoxic
stress are a primary phenotype, and are not due to clonal effects
or compensatory changes (Supplementary Fig. 2b). In sharp
contrast, IRE1α knockout MEFs did not reveal any differential
sensitivity to the ER stress inducer tunicamycin, in line with prior
results based on pharmacological inhibition of IRE1α16. Also, the
pharmacological inhibition of IRE1α RNase activity with MKC-
8866 increases the susceptibility to cell death after prolonged
genotoxic treatments (Fig. 1h, i). These findings highlight the
importance of IRE1α in the adaptation response to DNA damage.
The downstream effects of the DDR are mediated by
the activity of check point kinases CHK1 and CHK2, engaging
the tumor suppressor protein P53 to induce cell-cycle arrest
and the transcription of DNA damage-responsive genes, or
to trigger apoptotic cell death17. DDR signaling translates into the
phosphorylation of histone H2AX (γ-H2AX), and the rate of
γ-H2AX decay after DNA injury is a sign of DNA repair. Thus,
we monitored the kinetics of H2AX (de)phosphorylation after
exposing cells to a pulse of etoposide. IRE1α null cells exhibited a
lower response and faster attenuation of γ-H2AX phosphoryla-
tion compared to cells in which IRE1α was reintroduced (Fig. 2a).
Similar results were obtained when cells where exposed
to a shorter pulse of a higher concentration of etoposide
(Supplementary Fig. 2c). Analysis of nuclear γ-H2AX foci by
immunofluorescence and confocal microscopy also indicated
reduced γ-H2AX phosphorylation in IRE1α deficient cells
(Fig. 2b). To corroborate these results, we performed the comet
assay to directly visualize the DNA damage observing that
IRE1α knockout cells exposed to etoposide exhibited increased
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DNA damage (Fig. 2c). We also performed a cytokinesis-block
micronucleus cytome (CBMN) assay as an indirect measure of
DNA breaks. Cells were incubated with etoposide for 3 h,
followed by the administration of cytochalasin-B (CytB) for an
additional 24 h. IRE1α deficiency resulted in a higher percentage
of cells with binucleated nuclei, micronuclei or nuclear buds
(Fig. 2d). Altogether, these results suggest that IRE1α null cells
have reduced engagement of DNA repair programs.
A direct consequence of DNA damage is cell cycle arrest. No
significant differences were observed in cell proliferation
(Supplementary Fig. 3a) or cell cycle progression between control
and IRE1α null cells in normal conditions. Nevertheless, the
fraction of cells arrested in the S and G2/M phases was reduced in
IRE1α knockout MEFs exposed to etoposide (Fig. 2e). Similar
results were obtained when we reintroduced IRE1α in knockout
cells (Supplementary Fig. 3b). At the molecular level, the ablation
of IRE1α expression resulted in a strong attenuation in the
phosphorylation of CHK1 and CHK2 in DNA-damaged cells
(Fig. 2f). In contrast, the phosphorylation of the apical kinase
ataxia telangiectasia mutated kinase (ATM; an upstream sensor of
the DDR) was not altered in IRE1α knockout cells exposed to
etoposide (Fig. 2f and Supplementary Fig. 3c). Consistent with
these results, IRE1α knockout and WT MEF cells showed similar
phosphorylation of SMC118 and KAP119, two direct substrates of
ATM (Supplementary Fig. 3d), suggesting that the defects
triggered by IRE1α deficiency occur downstream of ATM
activation regulating CHK1 and CHK2 activation. Moreover,
IRE1α deficient cells showed a sustained kinetic of activation of
P53 (Supplementary Fig. 3e). Taken together, these results suggest
that IRE1α deficiency deregulates DDR signaling, thus affecting
cell cycle progression, DNA repair and cell survival under
genotoxic stress.
Genotoxic stress triggers RIDD to regulate DDR signaling. To
obtain mechanistic insights, we attempted to identify RIDD target
mRNAs that might connect IRE1α signaling to the DDR. Pre-
viously, a global in vitro screening uncovered a cluster of mRNAs
containing consensus sequences cleaved by IRE1α that are asso-
ciated to a stem-loop structurally similar to the Xbp1 mRNA
splicing site20. Among the 13 top hits, two DDR-related genes
were identified as possible RIDD substrates: PPP2CA-scaffolding
A subunit (Ppp2r1a) and RuvB like AAA ATPase1 (Ruvbl1)
mRNAs21 (Fig. 3a). PPP2R1A encodes the scaffold A subunit of
protein phosphatase 2 catalytic subunit alpha (PPP2CA, also
known as PP2A), which dephosphorylates check point kinases,
reversing the G2/M arrest, and directly catalyzing the decay of γ-
H2AX phosphorylation and foci22. RUVBL1 (also known as
Pontin), participates in chromatin remodeling and modulates the
stability of DDR protein complexes, thus influencing the de-
phosphorylation of γ-H2AX23.
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Fig. 1 Selective activation of RIDD under DNA damage. a MEF were treated with 10 μM etoposide (Eto) for indicated time points and phosphorylation
levels of IRE1α were detected by Phostag assay (p: phosphorylated 0: non-phosphorylated bands). IRE1α levels were analyzed by western blot. Treatment
with 500 ng/mL tunicamicyn (Tm) as positive control (8 h) (n= 3). b TREX-IRE1-3F6H-GFP cells were treated with 25 μM Eto (8 h) or 1 μg/mL Tm (4 h).
IRE1-GFP foci were quantified by confocal microscopy (>200 cells, n= 3). c MEF were treated with either 100 ng/mL Tm, 10 μM Eto or 25 Gγ of ionizing
radiation (IR) at indicated time points. Xbp1 mRNA splicing percentage was calculated by RT-PCR using densitometric analysis (left panel) (n= 3). d Xbp1s
mRNA levels were quantified by real-time-PCR in samples described in c (n= 3). e WT and IRE1α KO cells were treated with 10 μM Eto (8 h and 16 h), IR
(20 or 30 Gγ, 16 h) and the decay of mRNA levels of Bloc1s1 and Sparc was monitored by real-time-PCR. Treatment with 500 ng/mL Tm as positive control
(n= 3). f WT and IRE1α KO cells were treated with 25 μM Eto, 1 μM 5-fluorouracil (5-FU), 1 μM hydroxyurea (HU) or 1 μg/mL Tm by 24 h and viability
analyzed using propidium iodide (PI) staining and FACS (n= 3). g IRE1α KO (Mock) and IRE1α-HA reconstituted cells were treated with 10 µM Eto for 12 h
and apoptosis monitored by caspase-3 positive cells (green). Nucleus (Red) was stained to visualize cells number (n= 3). h MEF cells treated 36 h with
0.5 μM Eto in combination with the IRE1α inhibitor 25 μM MKC-8866. Representative images. i WT cells were treated with 0.5 and 1 μM Eto or in
combination with 25 μMMKC-8866 (36 h). Cell viability analyzed using PI staining and FACS (n= 3). All panels data is shown as mean ± s.e.m.; *p < 0.05,
**p < 0.01, and ***p < 0.001, based on b two-tailed unpaired t-Student’s test, (c, d). One-way ANOVA followed Tukey’s test (e–g, i), two-way ANOVA
followed Bonferroni’s test. Data is provided as a Source Data file.
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Quantification of Ppp2r1a and Ruvbl1 mRNA levels in cells
treated with etoposide demonstrated a decay that was dependent
on IRE1α expression (Fig. 3b). These effects on mRNA levels
translated into reduced protein expression of PP2A and RUVBL1
only in wild-type cells exposed to etoposide and the basal
upregulation in IRE1α null cells (Fig. 3c). In a cell-free assay,
recombinant IRE1α directly cleaves a fragment of the Ppp2r1a
mRNA that contains the RIDD consensus site (spanning
nucleotides 1336-1865), but not an adjacent fragment (Fig. 3d).
Similarly, IRE1α exhibited RNase activity on Ruvbl1 mRNA, thus
cleaving this substrate as efficiently as it’s known targets Bloc1s1
mRNA and Xbp1 mRNA (Fig. 3d). This reaction was suppressed
by the IRE1α inhibitor 4µ8C (Fig. 3d).
The lack of Xbp1mRNA splicing under DNA damage conditions
might involve inhibitory signals, for example mediated by the
downregulation of the tRNA ligase RTCB, the targeting of the Xbp1
mRNA to the ER membrane, or the activity of other regulatory
components that are part of IRE1α clusters and component
associated with them24. Analysis of RTCB levels revealed no
changes in IRE1a knockout cells undergoing DNA damage
(Supplementary Fig. 4a). To test if DNA damage inhibits Xbp1
mRNA splicing, we pre-treated cells with tunicamycin for 2 h and
then added etoposide at different time points. Remarkably,
etoposide failed to interfere with Xbp1 mRNA splicing induced
by tunicamycin (Fig. 3e). Virtually identical results were obtained
when a pulse of etoposide was performed followed by the
stimulation of ER stress (Fig. 3g). In contrast, an additive effect
was observed on the decay of Bloc1s1 and Sparc mRNAs when ER
stress and DNA damaging agents were combined (Fig. 3f, h). These
results indicate that DNA damage selectively engages RIDD yet
does not cause active suppression of Xbp1 mRNA splicing.
Considering that PP2A and Pontin are upregulated in IRE1α
null cells under genotoxic stress and are involved in the DDR, we
attempted to reverse the phenotype of those cells by depleting
Ppp2r1a or Ruvbl1 mRNA with suitable short hairpin RNAs
(shRNAs) (Supplementary Fig. 4b). Remarkably, knocking down
Ppp2r1a or Ruvbl1 in IRE1α null cells augmented the levels of
phosphorylated γ-H2AX foci after etoposide treatment during the
recovery phase (Fig. 3i). Similar results were obtained when
phosphorylated γ-H2AX was monitored by immunoblot (Sup-
plementary Fig. 4c). Moreover, knocking-down Ppp2r1a and
Ruvbl1 expression in IRE1α null cells reestablished normal levels
of CHK1 phosphorylation (Fig. 3j and Supplementary Fig. 4d, e)
and increased population of cells in S/G2M after etoposide
treatment (Supplementary Fig. 4f). Taken together, these
experiments suggest that the regulation of PP2A and Pontin by
IRE1α contributes to DDR signaling under genotoxic treatment.
c-Abl triggers IRE1α activation under DNA damage. Recent
studies suggest that IRE1α activation can occur independently
from ER stress, impacting various biological processes including
a
c d e f
b
Fig. 2 IRE1α deficiency impairs the DDR. a IRE1α KO (Mock) and IRE1α-HA reconstituted cells were pre-incubated with 1 μM etoposide (Eto) for 16 h and
washed three times with PBS and fresh cell culture media was added. The decay of phosphorylated H2AX (P-H2AX) was monitored over time by western
blot (middle panel). Quantification of the levels of P-H2AX in cells stimulated with Eto (bottom panel) (n= 3). b IRE1α KO (Mock) and IRE1α-HA
reconstituted cells were incubated with 10 μM Eto for 2 h and then washed with PBS and fresh culture media was added. The distribution P-H2AX
expression (green) was monitored by indirect immunofluorescence using confocal microscopy. Nuclei were staining with DAPI (Blue). Quantification of
P-H2AX per cell is shown (right panel) (n= 3). c WT and IRE1α KO MEFs cells were treated with 10 µM Eto for 3 h to perform the comet assay.
Quantification of tail intensity and tail moment (Tail intensity × tail area) is shown (right panel) (n= 3). d WT and IRE1α KO MEFs cells were treated with
5 μM Eto for 3 h to determined cytokinesis-block micronucleus cytome assay (CBMC). Binucleated cells (BN) with micronucleus (MN), nuclear buds
(Nbuds) or nucleoplasmid bridges (NPB; see arrows) were visualized and quantified using epifluorescence microscopy (n= 3). e WT and IRE1α KO MEFs
cells were treated with 10 μM Eto for 8 h and cell cycle was analyzed by propidium iodide (PI) staining. Quantification of the percentage of cells in G0/G1
and S phases is shown. f WT and IRE1α KO MEFs cells were treated with 10 μM Eto for indicated times. Expression and phosphorylation levels of indicated
proteins involved in the DDR were monitored by western blot (left panel). Quantification of the levels of p-CHK1 and p-CHK2 is shown (right panel) (n=
3). In all panels, data is shown as mean ± s.e.m.; *p < 0.05, **p < 0.01, and ***p < 0.001, based on (a, c, d, f) two-way ANOVA followed Bonferroni’s test,
b two-way ANOVA followed Tukey’s test. Data is provided as a Source Data file.
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cell migration, synaptic plasticity, angiogenesis and energy
metabolism14,24,25. However, until now there are no examples
for a selective activation of RIDD in the absence of Xbp1 mRNA
splicing. The release of the ER chaperone BiP from the luminal
domain of IRE1α correlates with its activation under ER stress4.
Co-immunoprecipitation experiments indicated that the BiP-
IRE1α interaction decrease after etoposide treatment, but in a
lesser extent than ER stress (Supplementary Fig. 5a).
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We then explored possible signaling events that may link the
DDR with the induction of RIDD. Interestingly, a recent report
indicated that the non-receptor c-Abl tyrosine kinase physically
interacts with IRE1α under metabolic stress, allosterically inducing
its oligomerization into a conformation that is more likely to
catalyze RIDD than Xbp1 mRNA splicing26. Of note, c-Abl has
been extensively associated to the DDR, regulating cell-cycle arrest
and apoptosis27. We confirmed the activation of c-Abl under
genotoxic stress (Supplementary Fig. 5b). Treatment of cells with
the c-Abl inhibitor imatinib reduced the decay of Ruvbl1 mRNA
in cells exposed to tunicamycin or etoposide (Supplementary
Fig. 5c, d). Furthermore, knocking down the expression of c-Abl
using shRNAs (Supplementary Fig. 5e) had no effects on the levels
of Xbp1 mRNA splicing (Fig. 4a), but fully prevented the decay of
Ruvbl1 and Ppp2r1a mRNAs under ER stress or DNA damage
(Fig. 4b), phenocopying the consequences of IRE1α deficiency.
Consistent with these results, imatinib treatment attenuated the
generation of IRE1α-GFP positive clusters in HEK293 cells
undergoing genotoxic stress (Fig. 4c, d). Moreover, we also
generated a set of c-Abl null MEF cells using the CRISPR/CAS9
technology (Fig. 4e). The deletion of c-Abl prevented the decay of
Ruvbl1, Ppp2r1a (Fig. 4f) and Bloc1s1 mRNAs, without an effect
on the levels of Xbp1 mRNA splicing (Supplementary Fig. 5f-g).
These observations correlated with the formation of a protein
complex between IRE1α and c-Abl as monitored using co-
immunoprecipitation in 293T HEK cells overexpressing the
proteins (Fig. 4g). We confirmed these results using Proximity
Ligation Assay of endogenous c-Abl and IRE1-HA at basal
conditions (Fig. 4h) or after exposure to etoposide (Supplementary
Fig. 5h, i). Furthermore, using a cell free system, we assessed the
effects of recombinant c-Abl on the oligomerization status of
purified cytosolic domain of IRE1α. Incubation of purified
IRE1α at 37 °C induced its spontaneous oligomerization, which
was further enhanced when c-Abl was present in the reaction
(Fig. 4i). Taken together, these results suggest that the activation of
c-Abl in cells undergoing DNA damage contributes to the selective
engagement of RIDD, possibly through a direct interaction
with IRE1α.
IRE1α protect flies against genotoxic stress. To test the possible
role of IRE1α in the maintenance of genome integrity in vivo, we
took advantage of D. melanogaster as a model organism. The
GAL4/UAS system was employed to knockdown the fly ortho-
logue of IRE1 (dIre1) using RNAi transgenic animals (Supple-
mentary Fig. 6a). Etoposide treatment failed to trigger an increase
in the levels of dXbp1s mRNA in larval tissue, as monitored by
real time PCR (Fig. 5a). However, larvae fed with etoposide or
tunicamycin exhibited a similar reduction in the mRNA levels of
dSparc and dMys, two well-known RIDD targets in flies28, in
addition to dPontin, fly orthologue of Pontin (Fig. 5b). dIre1
depletion ablated the downregulation of dSparc, dMys and
dPpp2r1a, confirming the occurrence of RIDD (Fig. 5b). More-
over, we then determined the impact of dIre1 on the survival of
animals under genotoxic conditions and quantified the number of
larvae reaching adulthood. Knock-down of dIre1 generated a
hypersensitivity phenotype, meaning that most etoposide-treated
animals died before reaching maturity (Fig. 5c). Next, we deter-
mined the participation of dIre1 in the maintenance of genome
integrity. To this end, we performed the somatic mutation and
recombination test (SMART). This assay is based on the induc-
tion of mutant spots (clones) that arise from loss of hetero-
zygosity in cells of developing animals, which are heterozygous
for a recessive wing cell marker mutation (Supplementary Fig. 6b)
generating a multiple wing hair (mwh) phenotype (Fig. 5d, left
panel). We expressed a dIre1 RNAi construct in the wing ima-
ginal disc using a Nubbin-Gal4 driver (Nub-Gal4). Exposure to
doxorubicin increased the number of mutant spots in the fly
wing, and this phenotype was exacerbated upon depletion of
dIre1 (Fig. 5d, right panel), suggesting compromised DNA repair.
Doxorubicin also caused higher rates of apoptosis-associated
caspase-3 activation upon dIre1 knockdown (Fig. 5e). Next, we
developed a mosaic analysis to ablate dIre1 expression with a
repressible cell marker (MARCM), a strategy that allows the
comparison of wild-type and mutant cells in the same tissue by
assessing GFP expression (Supplementary Fig. 6c). Using this
mosaic technology, we generated mutant clones for dIre1 in the
eye-antenna imaginal disc and determined the frequency of GFP-
positive (dIre1 null cells) and negative cells (WT cells) that persist
in the tissue after etoposide treatment. While dIre1 expressing
cells maintained their viability after exposure to etoposide (Fig. 5f,
left panels), dIre1 null cells proved highly susceptible to this
genotoxic agent (Fig. 5f, right panels). Taken together, these
results indicate that the fly orthologue of IRE1α protects against
genotoxic stress in vivo.
IRE1α deficiency impairs the DDR in mice. We then moved
forward and investigated the significance of IRE1α expression to
the DDR in vivo and deleted the RNase domain of IRE1α in the
liver and bone marrow using a conditional knockout (cKO)
system controlled by the Mx-Cre system29. Poly[I:C] was injected
to induce Cre expression, and three weeks later animals were
treated with a single dose of either etoposide or tunicamycin,
followed by the analysis of liver tissue. A well-established mam-
malian model of ER stress consists in the intraperitoneal injection
Fig. 3 IRE1α controls the stability of mRNAs involved in the DRR. a Putative IRE1α cleavage sites on the Ppp2r1a and Ruvbl1 mRNAs (blue arrows). b WT
and IRE1α KO MEF cells were treated with 10 μM etoposide (Eto). Ppp2r1a and Ruvbl1 mRNA levels were monitored by real-time-PCR. Treatment with
500 ng/mL tunicamicyn (Tm) as positive control (n= 3). c Cells were treated with 10 μM Eto (16 h) and PP2A and Pontin expression were monitored by
western blot (n= 3). d In vitro RNA cleavage assay was performed using mRNA fragments of human Ppp2r1a and Ruvbl1, incubated in the presence or
absence of recombinant cytosolic portion of IRE1α (IRE1α-ΔN) protein (30min). Experiments were performed in presence or absence of IRE1α inhibitor
4μ8C. Blos1c1 and Xbp1 mRNA were used as positive controls. e Experimental setup (upper panel): MEF cells were pretreated with 100 ng/mL Tm for 2 h
and then treated with 10 μM Eto. Xbp1 mRNA splicing was monitored by RT–PCR (bottom panel). f RIDD activity was monitored in samples described in
e (n= 3). g Experimental setup (upper panel): MEF WT cells were pretreated with 10 μM Eto for 2 h and then treated with 100 ng/mL Tm. Xbp1 mRNA
splicing was monitored by RT–PCR (bottom panel). h RIDD activity was monitored in samples described in g (n= 3). i IRE1α KOMEF cells were transduced
with lentiviruses expressing shRNAs against Ppp2r1a (shPpp2r1a), Ruvbl1 (shRuvbl1) or luciferase (shLuc). Cells were incubated with 1 μM Eto (16 h),
washed three times with PBS and fresh media was added. P-H2AX levels were monitored by immunofluorescence after 4 h. P-H2AX foci quantification is
shown (Bottom panel) (>200 cells, n= 4–5). j WT, IRE1α KO and reconstituted with IRE1α-HA, expressing shRuvbl1, shPpp2r1a or shLuc cells were treated
with 5 μM Eto for 8 h and P-CHK1 and P-ATM monitored by western blot. P-CHK1 quantification is shown (bottom panel) (n= 3). All panels data is shown
as mean ± s.e.m.; *p < 0.05, **p < 0.01, and ***p < 0.001, based on b two-way ANOVA followed Bonferroni’s test, (f, h–j) One-way ANOVA followed
Tukey’s test. Data is provided as a Source Data file.
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of tunicamycin, which elicits a rapid stress response in the liver.
Although evident signs of DNA damage were observed in both
control and IRE1αcKO animals (indicated by a rise in p21 mRNA)
(Fig. 6a upper panel and Supplementary Fig. 7a), no Xbp1 mRNA
splicing was detected in the etoposide treated group (Fig. 6a,
bottom panel). In sharp contrast, a clear down-regulation of
Ppp2r1a and Bloc1s1 mRNA levels occurred in the livers (Fig. 6b)
and bone marrows (Supplementary Fig. 7b) from control (but not
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Fig. 4 c-Abl contributes to the RIDD activation under DNA damage. a c-Abl was knocked down through the stable delivery of an shRNA. Then cells were
treated with 10 μM Etoposide (Eto) or 500 ng/mL tunicamicyn (Tm) for 8 h and Xbp1 mRNA splicing was monitored by RT–PCR (n= 3). b MEF ShRNA
Scramble and ShRNA c-Abl cells were treated with 10 μM Eto or 500 ng/mL Tm for 8 h, and the decay of Ppp2r1a and Ruvbl1 was measured by real-time-
PCR (n= 3). c Trex-IRE1-GFP cells were pre-treated with 10 μM imatinib by 1 h, and then treated with 10 μM Eto, or 500 ng/mL Tm for 8 h and IRE1-GFP
foci visualized by confocal microscopy. d Quantification of the percentage of cells positive IRE1-GFP clusters is shown (>200 cells, n= 3). e c-Abl
expression in CRISPR control and c-Abl KO cells was monitored by western blot (n= 3). f CRISPR control and c-Abl KO cells were treated with 10 μM Eto
or 500 ng/mL Tm for 8 h, and the decay of Ruvbl1 and Ppp2r1a was measured by Real-Time-PCR (n= 3). g HEK-293T cells reconstituted with IRE1α-HA
and c-Abl-GFP were exposed to 10 μM Eto for 8 h. Immunoprecipitation (IP) was performed using the HA epitope (IRE1α) and GFP (c-Abl) to assess the
possible interaction with c-Abl. h IRE1α KO (Mock) and reconstituted cells with an IRE1α-HA were treated 8 h with 10 μM Eto and stained with a proximity
ligation assay (PLA) using an anti-HA or anti-c-Abl antibodies and analyzed by confocal microscopy. Right panel: Number of dots per cell analyzed and
percentage of PLA positive cells were quantified (n= 6). i Recombinant IRE1α and c-Abl proteins were incubated at indicated time points and assess its
possible interaction by western blot. All data represents the mean ± s.e.m. of three independent experiments, except for co-IP that were performed twice.
*p < 0.05, **p < 0.01, and ***p < 0.001, based on (b, f) two-way ANOVA followed Bonferroni’s test, (d, h) One-way ANOVA followed Tukey’s test. Data is
provided as a Source Data file.
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IRE1α-deficient) animals injected with etoposide. Again, no Xbp1
mRNA splicing was detected in the etoposide treated group,
whereas exposure of animals to tunicamycin triggered a very mild
response in bone marrow tissue (Supplementary Fig. 7c). In
addition, IRE1α deficiency in the liver altered the DDR, reflected
in reduced phosphorylation of CHK1 in animals injected with
etoposide (Fig. 6c). Importantly, ablation of IRE1α resulted in
enhanced susceptibility of liver cells to apoptosis measured as
enhanced caspase-3 activation (Fig. 6d).
Finally, to assess the significance of IRE1α to the DDR on an
unbiased manner, we performed a gene expression profile
analysis of liver tissue derived from mice exposed to etoposide
or tunicamycin. Pathway enrichment analysis indicated that
IRE1α deficiency attenuated the establishment of a global DDR,
delayed the expression of cell cycle arrest genes and activated pro-
apoptotic pathways (Fig. 6e and Supplementary Fig. 8a). As
expected, under ER stress induced by tunicamycin, IRE1α
deficiency in the liver significantly impacted the expression of
genes involved in proteostasis control in the secretory
pathway (trafficking, folding and quality control) (Supplementary
Fig. 8b, c). Taken together, these findings demonstrate that IRE1α
signaling contributes to maintaining the stability of the genome
when cells face DNA damage.
Discussion
The current study supports a conserved function for IRE1α as a
signaling module of the DDR that differs from its canonical role
as an UPR mediator. We propose that IRE1α is part of a key
decision-making node in a complex interplay between cell sur-
vival and DNA repair upon genotoxic stress. In this context,
IRE1α regulates the levels of PP2A and RUVBL1 through the
selective engagement of RIDD, controlling the kinetics and
amplitude of γ-H2AX phosphorylation. The contribution of
IRE1α to genome stability is conserved in evolution from insects
to mammals and impacts whole animal survival as demonstrated
using flies. Our results suggest a regulatory mechanism in which
the RNase domain of IRE1α is selectively regulated to specifically
engage RIDD, presumably upon interaction with c-Abl (Fig. 4g,
h). This view is consistent with recent studies that connected
using unbiased approaches the pathways involved in maintenance
of genome integrity and proteostasis, showing that dysregulation
of the DDR resulted in protein aggregation and autophagy
induction30,31. Moreover, previous work demonstrated that the
function and structure of the ER is drastically affected by DNA
damaging agents used in chemotherapy32,33. Other recent reports
suggested that chronic ER stress suppresses DNA repair and sen-
sitizes cancer cells to ionizing radiation and chemotherapy34–37, in
addition to enhancing oxidative damage to the DNA38. Interest-
ingly, a recent study also reported that XBP1u, the protein encoded
by the unspliced version of Xbp1 mRNA, regulates the stability of
TP53, suggesting alternative connections between the UPR and the
DDR under resting conditions39. Our results suggest that IRE1α
specifically affects signaling events regulating the DDR, and not the
DNA damage sensing process. IRE1α operates as an amplification
loop, impacting the sustained activation of CHK1/2 and the
phosphorylation of γ-H2X through the control of the RIDD targets
Ppp2r1a and Ruvbl1, leading to cell cycle arrest and improved
DNA repair and as a consequence maintenance of cell survival
(see working model in Fig. 6f).
Although RIDD is proposed to be necessary for the main-
tenance of ER homeostasis8,10 and to contribute to the patho-
genesis of diabetes5, cancer40,41, and inflammatory conditions42–44,
most of the available evidence is difficult to interpret due to the
concomitant existence of Xbp1 mRNA splicing. Our study supports
a fundamental biological function for RIDD in the maintenance of
a
d e f
b c
dS
pa
rc
 m
R
N
A 
lo
g2
(t
re
at
ed
/u
nt
re
at
ed
)
dX
bp
1 
m
R
N
A 
le
ve
ls
(N
orm
a
liz
e
d)
dM
ys
 m
R
N
A 
lo
g2
(tr
ea
te
d/
un
tr
ea
te
d)
dP
on
tin
 m
R
N
A 
lo
g2
(tr
ea
te
d/
un
tr
ea
te
d)
Fig. 5 IRE1α expression confers protection against genotoxic stress in fly models. a D. melanogaster larvae were fed with 100 μM etoposide (Eto) or
50 μg/ml tunicamycin (Tm) for 4 h and then dXbp1s mRNA evaluated by real-time PCR and normalized to the expression levels of dRpl32 gene (n= 3).
b dIre1 mRNA was knocked down by expressing a specific RNAi constructs under the control of tubulin-Gal4 driver. D. melanogaster larvae were fed with
100 μM Eto or 50 μg/ml Tm for 4 h and the decay of RIDD targets dSparc, dPontin, and dMys mRNA was evaluated by RT-qPCR and normalized to the
expression levels of dRpl32 mRNA (n= 3). c Control and dIre1 knockdown larvae were fed with 500 μM Eto and allowed to reach adulthood for survival
analysis. The number of hatched flies was quantified (n= 20 per group) (n= 3). d A dIre1-RNAi expressing fly line was generated to specifically target
dIre1 in the imaginal disc of D. melanogaster. The wing SMART assays test was used to monitor genomic alterations after targeting dIre1 in flies. Larvae in
first instar were grown in food supplemented with the DNA damaging agent 0.125mg/ml doxorubicin (Dox) or 0.5% DMSO as control. Adult flies from
control and dIre1 RNAi larvae were fixed and the left wing analyzed for the number of mwh clones (right panel) (n= 3). e Using the same experimental
setting described in d, imaginal discs were collected, fixed and caspase-3 positive cells detected by immunofluorescence. Nucleus was stained with
TO-PRO3 to visualize total number of cells. Quantification of active caspase-3 cells per imaginal disc is presented (right panel) (n= 3). f Mutant knockout
dIre1 cells (dIre1 clone) in the eye-antenna imaginal disc were marked with GFP (see methods). Quantification of the ratio clone size/disc size is presented
(right panel) (n= 10 clones). In all panels, data is shown as mean ± s.e.m.; *p < 0.05, **p < 0.01, and ***p < 0.001, based on a one-way ANOVA followed
Tukey’s test, b–f two-way ANOVA followed Bonferroni’s test. Data is provided as a Source Data file.
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Fig. 6 IRE1α deletion in liver alters the DDR under genotoxic stress. a IRE1α was conditionally deleted the liver using the MxCre and LoxP system
(IRE1αcKO). Mice were intraperitoneally injected with 50mg/Kg etoposide (Eto) or 1 mg/Kg tunicamycin (Tm) and sacrificed 6 h and 16 h later. Total
mRNA levels of the deleted IRE1, and p21 were measured 6 h later in the liver by real-time-PCR (n= 3–4 mice per group). Xbp1 mRNA splicing (bottom
panel) was monitored in the same samples by RT-PCR. b Liver extracts of animals described in a, Ppp2r1a and Bloc1s1 mRNA expression levels were
measured 6 h later of Eto treatment by real-time-PCR (n= 3). c Protein liver extracts were obtained from mice treated described in a and the expression
levels of indicated proteins were monitored 6 h later of Eto treatment by western blot. Quantification of the levels of p-CHK1 is shown (Right panel). dMice
from a were intraperitoneally injected with 50mg/Kg Eto and sacrificed 48 h later. Then, livers active-caspase 3 detected by immunohistochemistry (n=
2–3). e Gene expression profile analysis was performed in mRNA from liver extracts of animals described in a. Most significant pathways altered by Eto
administration in WT and IRE1α null livers are shown. Three independent biological samples were used. In all panels, data is shown as mean ± s.e.m.; *p <
0.05, **p < 0.01, and ***p < 0.001, based on a–d two-way ANOVA followed Bonferroni’s test. Data is provided as a Source Data file. f Working model:
genotoxic stress activates IRE1α in the absence of ER stress markers, selectively engaging RIDD. IRE1α degrades mRNAs involved in the DNA damage
response encoding for Ppp2r1a and Ruvbl1, regulating the (de)phosphorylation of the histone H2AX and CHK-1/2. The non-canonical activation of IRE1α
involves the participation of the c-Abl kinase that is activated by DNA damage response kinases as ATM. The expression and function of IRE1α is essential
to promote survival under DNA damage conditions by controlling cell cycle arrest and DNA repair programs.
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genome integrity, representing a unique example for a selective and
specific activation of RIDD with clear physiological implications.
IRE1α is frequently affected by loss-of-function mutations in
cancer2,45, contrasting with the notion that cancer cells require
IRE1α to survive in hypoxic conditions3,6. Our present results
support the idea that the genetic alterations of IRE1α observed in
cancer may synergize with oncogenes to promote genomic
instability due to inefficient DNA repair. Altogether, we uncovered
a previously unanticipated function of a major UPR signal trans-
ducer as an integral component of the DDR, revealing an intimate
connection between the pathways that assure the integrity of the
proteome and the genome.
Methods
Reagents. Etoposide, doxorubicin, 5-fluorouracil, hidroxyurea, imatinib and 4μ8C
were purchased from Sigma Aldrich. Tunicamycin was obtained from Calbiochem
EMB Bioscience Inc. IRE1 inhibitor MKC-8866 was provided by Dr. John Pat-
terson (Fosun Orinove). Cell culture media, fetal calf serum, and antibiotics were
obtained from Life Technologies and Sigma Aldrich. Fluorescent probes and sec-
ondary antibodies coupled to fluorescent markers were purchased from Molecular
Probes, Invitrogen. All other reagents were obtained from Sigma or the highest
grade available.
Cell culture and DNA constructs. All MEF and HEK cells used here were
maintained in Dulbecco’s modified Eagles medium supplemented with 5% fetal
bovine serum, non-essential amino acids and grown at 37 °C and 5% CO2. IRE1α
deficient cells were previously described25. The production of amphotropic retro-
viruses using the HEK293GPG packing cell line was performed as described in
ref. 46. Retroviral plasmids were transfected using Efectene (Qiagen, Valencia, CA,
USA) according to the manufacturer’s protocols. IRE1α-HA expressing retro-
viruses were previously described in the pMSCV-Hygro vector46, where IRE1α
contains two tandem HA sequences at the C-terminal domain and a precision
enzyme site before the HA tag.
RNA isolation, RT-PCR and real time PCR. Total RNA was prepared from cells
and tissues using Trizol (Invitrogen, Carlsbad, CA, USA), and cDNA was syn-
thesized with SuperScript III (Invitrogen) using random primers p(dN)6 (Roche).
Quantitative real-time PCR reactions were performed using SYBRgreen fluorescent
reagent and/or EvaGreenTM using a Stratagene Mx3000P system (Agilent Tech-
nologies, Santa Clara, CA 95051, United States). The relative amounts of mRNAs
were calculated from the values of comparative threshold cycle by using Actin as a
control and Rpl19 or Rpl32 for RIDD substrates in mouse or D. melanogaster
samples, respectively. All methods for Xbp1 mRNA splicing assay were previously
described in ref. 47 using primers described in Supplementary Table 1.
Immunoprecipitations. HEK-293T cells reconstituted with IRE1α-HA and c-Abl-
GFP and IRE1α deficient MEF cells stably transduced with retroviral expression
vectors for IRE1α-HA or empty vector were incubated in presence or absence of
tunicamycin (500 ng/mL for 4 h) or etoposide (10 μM for 16 h). Cell lysates were
prepared for immunoprecipitations in lysis buffer (0.5% NP-40, 50 mM NaCl,
50 mM Tris pH 7.6, 50 mM NaF, 1 mM Na3VO4 and protease inhibitors).
Immunoprecipitations (IP) were performed as described48. In brief, to IP HA-
tagged IRE1α, protein extracts were incubated with anti-HA antibody-agarose
complexes (Roche), for 4 h at 4 °C, and then washed three times with 1 mL of lysis
buffer and then one time in lysis buffer with 350 mM NaCl. Beads were dried and
resuspended in Sample Buffer 2x. Samples were heated for 5 min at 95 °C and
resolved by SDS-PAGE 8% followed by western blot analysis.
Western blot analysis. Cells were collected and homogenized in RIPA buffer
(20 mM Tris pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% Triton X-100) containing a
protease inhibitor cocktail (Roche, Basel, Switzerland) in presence of 50 mM NaF
and 1mM Na3VO4. Protein concentration was determined in all experiments by
micro-BCA assay (Pierce, Rockford, IL), and 20–40 µg of total protein was loaded
onto 8–12% SDS-PAGE minigels (Bio-Rad Laboratories, Hercules, CA) prior
transfer onto PVDF membranes. To evaluate IRE1α phosphorylation, SDS-PAGE
minigel were made in presence of the 5 μM of Phostag reagent and 10 μM MnCl2.
Membranes were blocked using PBS, 0.1% Tween-20 (PBST) containing 5% milk
for 60 min at room temperature then probed overnight with primary antibodies.
The following antibodies diluted in blocking solution were used in this study: anti-
BiP 1:1000 (Abcam, Cat. ab21685); Anti-phosphorylated S139-H2AX 1:5000
(Millipore, Cat. 05-636), anti-DDIT3 (CHOP) 1:1000 (Santa Cruz, Cat. sc-575),
anti-XBP1s 1:1000 (Santa Cruz, Cat. 7160), anti-ATF4 1:2000 (Santa Cruz, Cat. sc-
200), anti-Hsp90 1:5000 (Santa Cruz, Cat. sc-13119), anti-IRE1α (14C10) (Santa
Cruz, Cat. 3294), anti-Chk1 1:1000 (Santa Cruz, Cat. sc-8408), anti-Chk2 1:1000
(Santa Cruz, Cat. sc-17747), anti-phosphorylated-Chk2, Thr68 1:1000 (Santa Cruz,
Cat. sc-16297-R), anti-ATM 1:1000 (Santa Cruz, Cat. sc-7129), anti-HA 1:1000
(Roche, Cat. 11666606001), anti-PP2A A 1:1000 (Cell Signaling technology, Cat.
2041S), anti-RuvbL1 1:1000 (Cell Signaling technology, Cat. 12300), anti-eIF2α
1:000 (Cell Signaling technology, Cat. 9722), anti-phosphorylated-eIF2α 1:1000
(Cell Signaling technology, Cat. 9721), anti-PERK 1:1000 (Cell Signaling technol-
ogy, Cat. 3192), anti-IRE1α 1:1000 (Cell Signaling technology, Cat. 3294), anti-
phosphorylated-Chk1, Ser348 1:1000 (Cell Signaling, Cat. 2341), anti-HA 1:1000
(Cell Signalling, Cat. 3724), anti-GAPDH 1:1000 (Cell Signaling, Cat. 21185), anti-
Abl 1:1000 (Sigma, Cat. A5844), anti-phosphorylated-c-Abl, pTyr412, 1:1000
(Sigma, Cat. C52490), anti-SMC1 1:1000 (Abcam, ab21583), anti-phosphorylated-
SMC1,Ser957, 1:1000 (Abcam, ab137871), anti-KAP1, 1:1000 (Abcam, ab190178),
anti-phosphorylated-KAP1, Ser824, 1:1000 (Abcam, ab70369), anti-
phosphorylated-ATM Ser 198 1:1000 (MERK, Cat. 05-740), anti-p21 (Santa Cruz,
Cat. sc-6246), anti-phospho-p53 (Cell Signalling, Cat. 9286 S), anti-p53 (Santa
Cruz, Cat. sc-98), anti-p53 (Santa Cruz, Cat. sc-55476). Bound antibodies were
detected with peroxidase-coupled secondary antibodies incubated for 1 h at room
temperature and the ECL system.
IRE1α oligomerization assay. TREX cells expressing IRE1α-3F6HGFP WT were
obtained from Dr. Peter Walter at UCSF and were previously described13. TREX
cells plated and treated with doxycycline (500 ng/mL for 48 h). Cells were treated
with Tm (1 µg/mL) or etoposide (25 μM) for different times points and fixed with
4% paraformaldehyde for 30 min. Nuclei were stained with Hoechst dye. Coverslips
were mounted with Fluoromount G onto slides and visualized by confocal
microscopy (Fluoview FV1000). The number and size of IRE1α foci was quantified
using segmentation and particle analysis of Image J software.
In vitro oligomerization assay. In all, 0.5 μg of the cytoplasmic domain of GST-
tagged IRE1α (Sino Biologicals) and 0.1 μg of His tagged c-Abl (Carna Biosciences)
were incubating and mixing for indicated time points, at 37 °C in a heat block
(300 rmp). Total reaction was prepared in 100 μL of oligomerization assay buffer
(50 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM MnCl2, 5 mM MgCl2, 1 mm DTT,
1 mM ATP). The half of the reaction mixture was mixed with NuPAGE LDS
sample buffer (Invitrogen) and loaded on 6% denaturing polyacrylamide gel and
subsequently analyzed by western blot.
Indirect Immunofluorescence. IRE1α-HA, and γ-H2AX proteins were visualized
by immunofluorescence. Cells were fixed for 30 min with 4% paraformaldehyde
and permeabilized 0.5% NP-40 in PBS containing 0.5% BSA (bovine serum
albumin) for 10 min. After blocking for 1 h with 10% FBS in PBS containing 0.5%
BSA, cells were subsequently incubated with anti-HA 1:1000 (Invitrogen, Cat.
715500), anti-phosphorylated-Chk1, Ser348 1:1000 (Cell Signaling, Cat. 2341),
anti-cleaved caspase 3, Asp175 1: (Cell Signalling, Cat. 9661) or anti-
Phosphorylated S139-H2AX 1:5000 (Millipore, Cat. 05-636) antibodies overnight
at 4 °C. Cell were washed three times in PBS containing 0.5% BSA, and incubated
with Alexa-conjugated secondary antibodies (Molecular Probes) for 1 h at 37 °C.
Nuclei were stained with Hoechst dye. Coverslips were mounted with Fluoromount
G onto slides and visualized by confocal microscopy (Fluoview FV1000).
Automated microscopy. Cells were seeded in 96-well imaging plates (BD Falcon,
Sparks, USA) 24 h before stimulation. Cells were treated with the indicated agents.
Subsequently, cells were fixed with 4% PFA and counterstained with 10 μM
Hoechst 33342. After blocking for 1 h with 10% FBS in PBS containing 0.5% BSA,
cells were subsequently incubated with anti-phosphorylated-Chk1, Ser345 1:1000
(Cell Signaling, Cat. 2348) antibody, overnight at 4 °C. Cell were washed three
times in PBS, and incubated with Alexa-conjugated secondary antibodies (Mole-
cular Probes) for 1 h at 37 °C. Images were acquired using an ImageXpress Micro
XLS Widefield High-Content Analysis System operated by the MetaXpress® Image
Acquisition and Analysis Software (Molecular Devices, Sunnyvale, CA, US).
Acquisition was performed by means of a 20X PlanApo objective (Nikon, Tokyo,
Japan). Minium 9 views fields per well for 96-wells plate were acquired. MetaX-
press® was utilised to segment cells into nuclear area (based on Hoechst
33342 signal). Cell-like objects were segmented and divided into cytoplasmic and
nuclear regions as previously reported49.
Proximity ligation assay (PLA). Cells were seeded in 12 mm cover slips. After the
indicated treatments, cells were fixed for 20 min at RT with 4% paraformaldehyde
and permeabilized 0.5% NP-40 in PBS containing 0.5% BSA (Bovine serum
albumin) for 10 min. After blocking for 1 h with 10% FBS in PBS containing 0.5%
BSA, cells were incubated with the indicated antibodies: Anti-HA (Cat: 901514,
Biolegend or Cat: 9110, Abcam) and anti-Abl 1:1000 (Sigma, Cat. A5844) over-
night at 4 °C following by Duolink manufacturer´s instructions (Duolink®, Sigma-
Aldrich). Images were acquired by confocal microscopy (Nikon C2 plus) using a
60X oil objective lens stacking the images every 0.5 µm to cover all the image of
interest. Stack images were deconvoluted using Huygens and ImageJ. Stack
deconvolved images were reduced to one dimension by sumslices function
(ImageJ). Colocalization was performed in thresholded and masked images were
used to determine Manders/Pearson’s index was calculated with ImageJ plugin.
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Comet assay. The comet assay was performed as previously described50. Briefly,
agarose-slides were prepared with 1% low-gelling-temperature agarose and 2 × 104
cells/ml and submerged in lysis solution (1.2 M NaCl, 100 mM Na2-EDTA, 0.1%
sodium lauryl sarcosinate, 0.26M NaOH (pH > 13)) for 18 h at 4 °C in the dark.
Then, carefully slides removed and submerged in room temperature (18− 25 °C)
in rinse solution (0.03 M NaOH, 2 mM Na2EDTA (pH ∼12.3)) for 20 min. elec-
trophoresis was conducted in the same solution for 25 min at a voltage of 0.6 V/cm.
Finally, slides were stained in a solution containing 2.5 µg/ml of propidium iodide
in distilled water for 20 min and observed in a epifluorescence microscopy. Images
were analyzed using Comet Assay IV software.
Cytokinesis-block micronucleus assay. Cytokinesis-block micronucleus (CBMN)
assay was performed as previously described51. In brief, cells were treated with 5
etoposide (5 μM for 3 h). Then, cells were washed three times with PBS and
incubated for 24 h with fresh media with 5 μM of Cytochalasin-B. Cells were fixed,
stained with Hoeschst. Binucleated cells (BN) with micronucleus (MN), Nuclear
buds (Nbuds) or nucleoplasmid bridges (NPB) were detected and quantified using
epifluorescence microscopy.
In vitro RNA cleavage assay. Bloc1s1 (NM_001487.3), Ppp2r1a (NM_014225)
and RuvbL1 (NM_00370) cDNA were obtained from MGC cDNA library
(Dharmacon). Long sense and antisense oligonucleotides containing a minimal T7
RNA polymerase promoter (5′-TAATACGACTCACTATAGG-3′) fused upstream
of the sequence containing different fragments of the genes Ppp2r1a, RuvbL1 and
Bloc1s1 harboring 5′-EcoRI and 3′-BamHI overhangs were annealed and ligated
into the cognate restriction sites of pUC19 (Invitrogen, Life Technologies). Oli-
gonucleotides sequence to clone Ppp2r1a and RuvbL1 fragments were described
previously20. In vitro transcription reactions were performed with T7 RNA poly-
merase using the HiScribe T7 high-yield RNA synthesis kit (New England Biolabs)
following the manufacturer’s recommendations. The transcribed RNA were treated
for 20 min with DNase and purified by urea-polyacrylamide gel electrophoresis
(urea–PAGE). RNAs recovered from gel fragments by the crush-and-soak method,
were precipitated with 300 mM NaOAc and 1 volume of isopropanol. No co-
precipitants were employed. The precipitated RNA pellets were desalted by two
washes with 70% ice-cold ethanol, air-dried and re-suspended in an appropriate
volume of either nuclease-free water or RNA resuspension buffer (20 mM HEPES,
100 mM NaCl, 1 mM Mg(OAc)2). The oligonucleotides sequence used are listed in
the Supplementary Table 2.
The cytosolic kinase/ribonuclease domain construct of IRE1α (KR43) was
expressed and purified as described previously52. In vitro transcribed, PAGE-
purified, refolded RNAs (50 ng) were incubated with 0.5 μM IRE1α-KR43 for the
indicated times in RNA cleavage buffer (20 mM HEPES pH 7.5, 70 mM NaCl,
2 mM Mg(OAc)2, 1 mM TCEP, and 5% glycerol). Stop solution (10M urea, 0.1%
SDS, 1 mM EDTA, 0.05% xylene cyanol, 0.05% bromophenol blue) was added at
five-fold excess to stop the reactions followed by heating at 80 °C for 3 min. The
denatured samples were then loaded on 6% TBE–urea gels (Invitrogen, Life
Technologies) and the gels stained with SYBR Gold nucleic acid stain (Invitrogen,
Life Technologies). As a negative control we utilized the IRE1α inhibitor 4μ8C to a
final concentration of 5 μM.
Viability assay. In all, 2.0 × 104 cells were seeded in 48-well plate and the main-
tained by 24 h in DMEM cell culture media supplemented with 5% bovine fetal
serum and non-essential amino acids. Genotoxic and ER stress were induced by
adding genotoxic and ER stress agents to the cells at different concentrations, and
maintained for 24 h. Then, cell viability was monitored using propidium iodide
staining and flow cytometry (BD FACS Canto, Biosciences).
Mouse model. Ern1 floxed mice were previously described53 and crossed with
Mx1-cre transgenic mice to generate a conditional KO animal (IRE1αcKO). Dele-
tion was induced by injection of polyinosinic-polycytidylic acid (Poly (I:C)) which
efficiently delete the floxed gene in the liver and bone marrow29. I all, 5–6-weeks-
old mice were intraperitoneally (i.p) injected three times with 250 µg of poly(I:C)
each time with 2 day intervals to induce the Cre expression. Mice were used for
experiments at least 2–3 weeks after the final poly (I:C) injection. DMSO or 50 mg/
Kg etoposide or 1 mg/Kg tunicamycin or were i.p. injected and 6 h later mice were
sacrificed as reported54. The liver and bone marrow were frozen at −80 °C for
biochemical analysis and the right major lobe of the liver was placed in a petri dish
(on ice). Liver tissue was washed in PBS to remove the blood and then, it was fixed
in 4% paraformaldehyde (72 h) for histological analyses. The animals’ works and
care was in accordance with institutional guidelines. Institutional Committee for
Animal Care and Handling, University of Chile (Protocol CICUA-CBA-0833).
Fly studies. Flies were kept at 25 °C on standard medium with a 12–12 dark–light
cycle. Drug administration protocol for all experiments is as follows: Larvae were
grown in standard fly medium until day 3 after egg lying (AEL). Then they were
transferred to fly instant medium (Carolina Biological Supply 2700 York Bur-
lington, NC, USA) complemented with the appropriate drug for the different
treatments. Larvae were fed with the corresponding drug-supplemented media
until dissection or adulthood.
The UAS-Ire1 IR (v39562) line was obtained from the Vienna Drosophila RNAi
Center (VDRC). The following lines were obtained from Bloomington Drosophila
Stock Center (BDSC): UAS-GFP IR (BL-44412); Ire1 mutant w1118; PBac{WH}
Ire1f02170/TM6B (BL-18520); mwh1 mutant (BL-549) and flr3/TM3, Ser stock
(BL-2371). All fly strains are listed in the Supplementary Table 3.
SMART assay. For the SMART assay, larvae were fed in media complemented
with 0.125 mg/mL Doxorubicin. Wings of the hatched female flies were fixed in
ethanol, mounted in ethanol:lactic acid 1:1, and 15 wings per condition were
analyzed at ×400 magnification for the occurrence of mutant clones (N= 4)55.
Survival curve and biochemical analysis of fly tissue. Survival analyses were
carried out growing 20 experimental or control larvae in 500 μM etoposide and the
number of living animals was quantified at different time points. For real time RT-
PCR analysis, total RNA was extracted from third instar larvae (same treatment as
the survival analysis animals) using Trizol (Invitrogen, Carlsbad, CA, USA), and
cDNA was synthesized with SuperScript III (Invitrogen)56,57.
For immunohistochemistry, larvae were fed with 0.125 mg/mL doxorubicin.
Then third instar larvae were dissected and fixed as described previously58.
Larvae carcasses were incubated with Anti-caspase-3 (1:100, Cell Signaling)
overnight in PBT supplemented with 0.5% BSA at 4 °C, washed four times with
PBT for 15 min and stained with Alexa-conjugated secondary antibody (1:200,
Molecular Probes) and TO-PRO3 (1 μM, Invitrogen). VectaShield (Vector
Laboratories, Burlingame, California, USA) was used as a mounting media. The
number of active Caspase-3 positive cells was quantified in 10 wing imaginal
discs (N= 3). Images were taken using a Zeiss LSM510 confocal microscope and
analyzed with ImageJ software.
Microarray analyses. Affymetrix gene expression data were pre-processed using
Transcriptome Analysis Console (TAC) (v4.0, ThermoFisher Scientific). Custom
mouse Brainarray chip definition (v22) was used to further annotate the DE files
with Entrez and gene symbol IDs. For further analysis, just gene transcript with
FDR (a= 0.05) correction and 1.5 > fold change was considerated. For pathway
enrichment analysis, data obtained from untreated wild type or IRE1αcKO after
poly I:C treatment liver mice tissues were used as reference for tunicamycin (Tm)
and etoposide (Eto) treatment comparisons, to further input them in ClueGO
(v2.3.2) software using Reactome pathway enrichment database (v09.11.2016).
In addition, to visualize patterns in the gene expression and pathway enrichment
scores for specific ontologies, heatmaps were generated using RStudio (v0.99.489, R
3.4.1) based on KEGG pathway database gene lists. Genes which show change of
the ratios higher (or lower) than 1.5-fold in the arrays at any comparison have been
considered as up or downregulated and subjected for functional enrichment ana-
lysis. The Bioconductor package ‘clusterProfiler’ was applied to perform functional
enrichment analysis using the following repositories: GO (Gene Ontology), KEGG
(Kyoto Encyclopedia of Genes and Genomes), and Reactome Pathways. GEO
Dataset ID: GSE130952.
Statistical analysis. Results were statistically compared using the Ordinary One-
way ANOVA and Two-way ANOVA followed by different multiples comparison
post-tests (Tukey’s Multiple Comparison Test or Bonferroni’s Multiple Com-
parison Test). When pertinent, Student’s t-test was performed for unpaired or
paired groups. In all plots p values are show as indicated: *: p < 0.05, **: p < 0.01,
***: p < 0.001 and ****: p < 0.0001 and were considered significant. n.s: non-
significant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figures and Supplementary Figures are provided as a Source
Data file. All data is available from the corresponding author upon reasonable request.
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